FDA to Revise Safety Evaluation of Type 2 Diabetes Drugs FDA to Revise Safety Evaluation of Type 2 Diabetes Drugs

New draft guidance will replace the 2008 requirement for cardiovascular outcomes trials and instead require a broader array of safety data.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news